Safety and Efficacy of Adding Nalbuphine to Bupivacaine in Transversus Abdominis Plane Block in Laparoscopic Bariatric Surgery: A Randomised Controlled Trial.
Phase 3
- Conditions
- SurgeryAnaesthesia
- Registration Number
- PACTR202208575341765
- Lead Sponsor
- Cairo University Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Obese patients with BMI = 35 kg/m2
Obese patients aged between 19 and 65 years of age
Elective laparoscopic bariatric surgery.
American Society of Anesthesiology physical status II and III
Exclusion Criteria
Known allergy to nalbuphine and/or Bupivacaine
Chronic opioid users
Chronic pain conditions (consuming regular analgesics > 3 months)
History of neurological diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method